title: Robotic stereotactic radiosurgery in patients with unresectable glomus jugulare tumors.
abstract: We evaluated the treatment results of robotic stereotactic radiosurgery (SRS) in our patients with unresectable glomus jugulare tumors (GJTs). The medical charts of fourteen patients with GJT, who were treated with robotic SRS, were retrospectively evaluated. The gross tumor volume was described as the clinical target volume. The median dose to the tumor was 25 Gy in median 5 fractions. The dose was normalized to 80% isodose line. All patients were evaluated for tumor growth and clinical outcome every 6 months in the first 2 years and then annually. Median follow-up was 39 months (range, 7-60 months). Lesions were stable in 8 patients, and tumor regression was observed in 6 patients. We did not observe any treatment related toxicity in our patients. In conclusion, according to our early experience, robotic SRS seems to be successful treatment option in the management of unresectable GJTs.
authors.affiliation: Hacettepe University Faculty of Medicine, Department of Radiation Oncology, 06100, Sihhiye, Ankara, Turkey.
authors.forename: P
authors.initials: P
authors.lastname: Hurmuz
authors.forename: M
authors.initials: M
authors.lastname: Cengiz
authors.forename: G
authors.initials: G
authors.lastname: Ozyigit
authors.forename: G
authors.initials: G
authors.lastname: Yazici
authors.forename: F
authors.initials: F
authors.lastname: Akyol
authors.forename: F
authors.initials: F
authors.lastname: Yildiz
authors.forename: M
authors.initials: M
authors.lastname: Gurkaynak
authors.forename: F
authors.initials: F
authors.lastname: Zorlu
mesh_terms: D000328:Adult; D000368:Aged; D019583:Dose Fractionation, Radiation; D005260:Female; D005925:Glomus Jugulare Tumor / Q000401:mortality / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016634:Radiosurgery; D012189:Retrospective Studies; D012371:Robotics; D025321:Surgery, Computer-Assisted; D016896:Treatment Outcome